LifeGen co-founders, Richard Weindruch and Tomas Prolla will also hold positions on the newly formed Nu Skin Anti-aging scientific advisory board.
Nu Skin's agreement with Stanford aims to increase the understanding of fundamental aging mechanisms in human beings by translating insights from basic science into human application. The agreement also includes access to Stanford's expertise in dermatological clinical trials.
Nu Skin will collaborate with LifeGen in an exclusive agreement by leveraging LifeGen's proprietary methods regarding gene expression profiling and pathways affected by aging. LifeGen was co-founded in November 2000 by Drs Weindruch and Prolla, professors at the University of Wisconsin-Madison and leaders in the fields of gerontology and genetics.
Joseph Chang, chief scientific officer of Nu Skin, said: "Nu Skin has established a 25-year legacy of product innovation and our research agreements with Stanford University and LifeGen Technologies add significant fuel to our scientific engine. We believe that these collaborative relationships will help us develop next-generation skin care and nutritional products from an enhanced understanding of the genetic basis of aging."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index